Rhenman & Partners Asset Management AB - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$327,443
-78.9%
253,832
-78.1%
0.04%
-79.4%
Q1 2023$1,551,175
-15.6%
1,157,593
-5.5%
0.17%
-11.5%
Q4 2022$1,837,622
+105.8%
1,225,0810.0%0.19%
+104.3%
Q3 2022$893,000
-35.5%
1,225,0810.0%0.09%
-40.1%
Q2 2022$1,384,000
-63.8%
1,225,081
-4.1%
0.16%
-58.4%
Q1 2022$3,821,000
-6.2%
1,277,770
-15.9%
0.38%
+39.1%
Q4 2021$4,074,000
-26.2%
1,520,0000.0%0.27%
-30.0%
Q3 2021$5,518,000
-16.4%
1,520,0000.0%0.39%
-13.6%
Q2 2021$6,597,000
+26.9%
1,520,0000.0%0.45%
+23.8%
Q1 2021$5,198,000
-14.5%
1,520,000
-12.5%
0.36%
-27.0%
Q4 2020$6,077,000
+45.8%
1,736,1760.0%0.50%
+33.7%
Q3 2020$4,167,000
+31.2%
1,736,1760.0%0.37%
+8.2%
Q2 2020$3,177,000
+17.3%
1,736,1760.0%0.34%
-9.5%
Q1 2020$2,708,000
-33.4%
1,736,176
-8.6%
0.38%
-15.0%
Q4 2019$4,066,000
+8.7%
1,900,000
-5.0%
0.45%
-4.9%
Q3 2019$3,740,000
-36.7%
2,000,000
-11.7%
0.47%
-28.0%
Q2 2019$5,911,000
+1.5%
2,264,9420.0%0.65%
-4.4%
Q1 2019$5,821,000
+11.7%
2,264,9420.0%0.68%
+14.5%
Q4 2018$5,209,000
-23.2%
2,264,942
+7.1%
0.60%
-12.5%
Q3 2018$6,786,000
+40.8%
2,113,988
+24.1%
0.68%
+37.9%
Q2 2018$4,820,000
-15.8%
1,703,278
+5.3%
0.49%
-30.2%
Q1 2018$5,727,000
-23.6%
1,617,769
-16.3%
0.71%
-30.3%
Q4 2017$7,499,000
+25.6%
1,932,831
-17.8%
1.01%
+32.9%
Q3 2017$5,969,000
+58.9%
2,350,000
+70.8%
0.76%
+41.4%
Q2 2017$3,756,000
-11.5%
1,375,900
+7.3%
0.54%
-19.8%
Q1 2017$4,243,000
+39.1%
1,282,0000.0%0.67%
+14.9%
Q4 2016$3,051,000
-99.9%
1,282,000
-8.4%
0.58%
-28.3%
Q3 2016$5,138,000,000
+270891.6%
1,400,000
+64.7%
0.82%
+142.1%
Q2 2016$1,896,000
+7.2%
850,0000.0%0.34%
-4.0%
Q1 2016$1,768,000
-30.9%
850,000
+0.7%
0.35%
-9.3%
Q4 2015$2,558,000
+11.9%
844,313
-8.7%
0.39%
+6.3%
Q3 2015$2,285,000
-23.0%
925,0000.0%0.36%
+2.0%
Q2 2015$2,969,000
-16.8%
925,000
-7.5%
0.36%
-40.7%
Q1 2015$3,570,0001,000,0000.60%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders